Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment.
Ontology highlight
ABSTRACT: Neoadjuvant chemotherapy (NACT) used for triple negative breast cancer (TNBC) eradicates tumors in ~45% of patients. Unfortunately, TNBC patients with substantial residual cancer burden have poor metastasis free and overall survival rates. We previously demonstrated mitochondrial oxidative phosphorylation (OXPHOS) was elevated and was a unique therapeutic dependency of residual TNBC cells surviving NACT. We sought to investigate the mechanism underlying this enhanced reliance on mitochondrial metabolism. Mitochondria are morphologically plastic organelles that cycle between fission and fusion to maintain mitochondrial integrity and metabolic homeostasis. The functional impact of mitochondrial structure on metabolic output is highly context dependent. Several chemotherapy agents are convent
SUBMITTER: Baek ML
PROVIDER: S-EPMC10069007 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA